“We urgently need to fix dementia diagnosis and this innovative research, funded by Alzheimer’s Society, could help to bring us closer to a future of accessible tools for early and accurate dementia ...

Getting an early and accurate diagnosis of the disease causing a person’s dementia remains a huge challenge. Dr Lengyel is investigating the eye health of people living with Down’s syndrome and mild ...

Dr Harry Pritchard will develop new animal models to study the mechanisms behind reduced blood flow to the brain in Alzheimer’s disease and vascular dementia. Through his work, Dr Pritchard aims to ...

Tau is a protein that builds up and moves between nerve cells in the brains of people living with Alzheimer’s disease, causing damage. Professor Mudher is using clever genetic manipulation in fruit ...

“The development of a drug to cross the blood brain barrier that would be able to block… inflammation in the brain is something that needs to be looked into, [especially if] this ultimately leads to a ...

With limited treatment options available for Alzheimer’s disease, researchers must focus on understanding the mechanisms of the disease and developing new treatments. Dr Jiang’s research is going to ...

Vascular dementia is the second most common form of dementia. Currently, we cannot predict who is likely to develop vascular dementia, and there is no cure. Research by Dr Eric Harshfield has two aims ...

Making Evaluation Count involves seeking feedback from people living with dementia and carers about the Alzheimer's Society services they receive from our support workers. Support to participate is ...

Healthwatch Essex used qualitative data about the experience of living in Essex with dementia to inform their commissioning strategy for services from 2017. They also produced a useful report. Essex ...

In Shropshire, working with people with dementia led to the introduction of a new role, the 'Dementia Companions', who help with personalised care planning. Services needed a shared vision to enable ...

Dr Sarah Ryan’s research aims to understand the role of brain’s immune cells, microglia, in frontotemporal dementia, and whether addressing brain inflammation could be a new therapeutic target.